Start
Features
Free trial / FAQ

Researchers
Physicians
Pharmacists
Ecotrophologists
Product Managers
in Health Industries

Loading…

Medical Research Finder

Legal Notice
Privacy
Terms of Use

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

meRfi® AI Chat

Cyclin-dependent kinase 4 inhibitor D (CDKN2D)

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

(Login)

Navigation

Cyclin-dependent kinase 4 inhibitor D (CDKN2A) is not a drug or medication. It is an endogenous physiological inhibitor - a tumor suppressor that functions naturally within human cells.
Lee et al. 2021 J of Cancer 12(17): 5086-5098

…

References (Sources)

Histone Deacetylase Inhibitor-Induced CDKN2B and CDKN2D Contribute to G2/M Cell Cycle Arrest Incurred by Oxidative Stress in Hepatocellular Carcinoma Cells via Forkhead Box M1 Suppression
Lee et al. 2021 J of Cancer 12(17): 5086-5098
Overall survival in patients with hormone receptor-positive, HER2-negative, advanced or metastatic breast cancer treated with a cyclin-dependent kinase 4/6 inhibitor plus fulvestrant: a US Food and Drug Administration pooled analysis
Gao et al. 2021a The Lancet Oncology 22: 1573-1581

AI Chat

7/1/2026

Chat with our artificial intelligence:

Start chat!

Cyclin-dependent kinase 4 inhibitor D (CDKN2D)

Welcome to meRfi Microbiome!

Navigation

Contents

References (Sources)

AI Chat

Links